Get the app
US › Healthcare

Compass Pathways Plc (CMPS)

US · Healthcare · Medical Care Facilities

$8.61+10.24%
Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Net profit
$-9.8M
EPS
$-0.31
EPS estimate
$-0.39

EPS came in at -0.31 against a street estimate of -0.39 — a beat of 20.5%.

Key statistics

Market cap
$1.22B
Forward P/E
0.0
P/B
14.07
Book value
$1.00
EPS (TTM)
$-2.34
52-week high
$15.87
52-week low
$4.88
50-day MA
$12.57
200-day MA
$10.42
Beta
2.41

Analyst view

Analysts rate Compass Pathways Plc a strong buy (15 buy, 1 hold, 0 sell out of 16) with an average price target of $23.75.

Shareholding

Insiders
7.45%
Institutions
70.18%

Largest institutional holders

FundStake
Deep Track Capital, LP8.78%
RTW INVESTMENTS, LLC7.73%
TANG CAPITAL MANAGEMENT LLC3.61%
Two Sigma Investments LLC3.23%
Marshall Wace Asset Management Ltd3.13%
ARK Investment Management LLC2.49%
Point72 Asset Management, L.P.1.89%
Logos Global Management LP1.62%

Recent filings & reports

DocumentDate
Quarterly report · Q3 2026
HEADLINE NUMBERS • Nine-month 2026 net loss was $172,423, compared with $193,984 in the same period of 2025. • Third-quarter 2026 net loss was $9,83
2026-11-03
Results announced · Q4 2026
HEADLINE NUMBERS • Cash and cash equivalents were $444.0 million at September 30, 2026, up from $149.6 million at December 31, 2025. • Third-quarter
2026-11-03
Quarterly report · Q2 2026
COMPASS PATHWAYS PLC — Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Cash position: $433.3 million as of June 30, 2026 (vs $149.6 million at December 31,
2026-08-05
Results announced · Q3 2026
COMPASS PATHWAYS PLC – Q2 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Cash and cash equivalents: $433.3 million as of June 30, 2026 (vs. $149.6 millio
2026-08-05
Reg FD disclosure · Q3 2026
COMPASS PATHWAYS PLC – FORM 8-K SUMMARY HEADLINE NUMBERS • COMP006 Part B efficacy (26 weeks): 39% of participants in 25 mg arm achieved clinically
2026-07-07
Shareholder vote results · Q2 2026
COMPASS PATHWAYS PLC - FORM 8-K SUMMARY HEADLINE NUMBERS • Annual General Meeting (AGM) held May 27, 2026 with 58,880,058 ordinary shares represente
2026-05-28
Quarterly report · Q1 2026
COMPASS PATHWAYS PLC – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Cash position: $466.0 million as of March 31, 2026 (up from $149.6 million at Decembe
2026-05-13
Results announced · Q2 2026
COMPASS PATHWAYS PLC – Q1 2026 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Net income $91.2 million for Q1 2026 vs. net loss of $17.9 million in Q1
2026-05-13

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Compass Pathways Plc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-11-07.